123 - Breaking Biotech Week End Wrap Up - Nov 21, 2026 xitter.cf/i/broadcasts/2WXZYQqeq…
5
263
Given the wording of the CRL, I wouldn't be surprised if an opportunistic lawyer gets interested
The PharmaBro @MartinShkreli got liquidated on his $CAPR short back in December (along with plenty of others who followed him).
At the time he called the results fraudulent and said CEO Linda Marbán would end up in jail. Turns out he was right.
$CAPR is down ~80% after hours after the FDA rejected the supplemental BLA with a strong CRL. The language specifically called out serious data integrity problems in a key trial - highly unusual and unusually pointed.
@FDA has to set an example here.
If I were @linda_marban , I’d be worried.
Don’t bet against the pharma bro.
3
459
lol Huberman joins $HIMS BoD, what a circus
investors.hims.com/news/news…
3
632
Baker Bro's buying $24M more $KOD in the open market (avg. price $98.51)
kodiak.gcs-web.com/sec-filin…
Nice to see another deal $RYTM! Feels like an expensive acquisition given the size of HO, but they must be confident about the potential in other MC4R-related obesity indications
After listening to the call, a couple of points stand out:
- They refused to share details on early access customers/placements (fair to assume they haven't added anymore)
- They haven't gotten buy-in from academics to submit S-10 grants (i.e. unlikely to have any academic instrument revenue until well into 2028)
Seems like the company has big plans, but is still slow to execute with no sign that things are going to change.
This should be trading below cash imo. Will see how the rest of the week plays out before considering more shorts.
1
222
$NAUT Q3 earnings:
- $0.2M revenue (only 26K of that from services)
- No ATM use in Q3
- Net loss: ~$16M
- Cash $114M
Will have to listen to the call to see if they have any more placements, but looks like another quarter without much adoption
3
4
1,641
Breaking Biotech Week End Wrap Up - Oct 25th, 2026 xitter.cf/i/broadcasts/1aKbdEWPD…


